ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Post-Traumatic Stress Disorder (PTSD) Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-2L2344
Home | Market Reports | Health| Mental Health
Global Post Traumatic Stress Disorder PTSD Market Insights and Forecast to 2028
BUY CHAPTERS

Global Post-Traumatic Stress Disorder (PTSD) Market Research Report 2025

Code: QYRE-Auto-2L2344
Report
September 2025
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GlaxoSmithKline UK
Pfizer (US)
Eli Lilly and Company (US)
Lundbeck A/S (Denmark)
Azevan Pharmaceuticals (US)
Marinus Pharmaceuticals, Inc. (US)
Tonix Pharmaceuticals Holding Corp. (US)
Bionomics (Australia)
Greenstone LLC (US)
Mylan NV (US)
Otsuka Pharmaceutical (Japan)
Prometheon Pharma (USA)
Ligand Pharma (USA)
Valenta Pharm (Russia)
Lycera Corp (US)
Archimedes (UK)
GMP Endotherapeutics (USA)
Nuvo Pharmaceuticals (Canada)
Beijing Wansheng Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Jianfeng Pharmaceutical

Post-Traumatic Stress Disorder (PTSD) Market

The global market for Post-Traumatic Stress Disorder (PTSD) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Post-traumatic stress disorder (PTSD) is a delayed and persistent mental disorder that occurs when an individual experiences, witnesses, or encounters one or more actual deaths involving himself or others, or is threatened with death, or is severely injured, or whose physical integrity is threatened.The incidence of PTSD has been reported inconsistently, with women more likely to develop PTSD than men.
North American market for Post-Traumatic Stress Disorder (PTSD) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Post-Traumatic Stress Disorder (PTSD) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Post-Traumatic Stress Disorder (PTSD) in Children is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Post-Traumatic Stress Disorder (PTSD) include GlaxoSmithKline (UK), Pfizer (US), Eli Lilly and Company (US), Lundbeck A/S (Denmark), Azevan Pharmaceuticals (US), Marinus Pharmaceuticals, Inc. (US), Tonix Pharmaceuticals Holding Corp. (US), Bionomics (Australia), Greenstone LLC (US), Mylan NV (US), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Post-Traumatic Stress Disorder (PTSD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Post-Traumatic Stress Disorder (PTSD).
The Post-Traumatic Stress Disorder (PTSD) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Post-Traumatic Stress Disorder (PTSD) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Post-Traumatic Stress Disorder (PTSD) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Post-Traumatic Stress Disorder (PTSD) Market Report

Report Metric Details
Report Name Post-Traumatic Stress Disorder (PTSD) Market
Segment by Type
  • Cognitive Therapy
  • Exposure Therapy
  • Eye Movement Desensitization And Reprocessing (EMDR)
  • Antidepressants
  • Anti-Anxiety Medications
  • Prazosin
Segment by Application
  • Children
  • Adult
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GlaxoSmithKline (UK), Pfizer (US), Eli Lilly and Company (US), Lundbeck A/S (Denmark), Azevan Pharmaceuticals (US), Marinus Pharmaceuticals, Inc. (US), Tonix Pharmaceuticals Holding Corp. (US), Bionomics (Australia), Greenstone LLC (US), Mylan NV (US), Otsuka Pharmaceutical (Japan), Prometheon Pharma (USA), Ligand Pharma (USA), Valenta Pharm (Russia), Lycera Corp (US), Archimedes (UK), GMP Endotherapeutics (USA), Nuvo Pharmaceuticals (Canada), Beijing Wansheng Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Jianfeng Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Post-Traumatic Stress Disorder (PTSD) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Post-Traumatic Stress Disorder (PTSD) Market report?

Ans: The main players in the Post-Traumatic Stress Disorder (PTSD) Market are GlaxoSmithKline (UK), Pfizer (US), Eli Lilly and Company (US), Lundbeck A/S (Denmark), Azevan Pharmaceuticals (US), Marinus Pharmaceuticals, Inc. (US), Tonix Pharmaceuticals Holding Corp. (US), Bionomics (Australia), Greenstone LLC (US), Mylan NV (US), Otsuka Pharmaceutical (Japan), Prometheon Pharma (USA), Ligand Pharma (USA), Valenta Pharm (Russia), Lycera Corp (US), Archimedes (UK), GMP Endotherapeutics (USA), Nuvo Pharmaceuticals (Canada), Beijing Wansheng Pharmaceutical, Zhejiang Huahai Pharmaceutical, Zhejiang Jianfeng Pharmaceutical

What are the Application segmentation covered in the Post-Traumatic Stress Disorder (PTSD) Market report?

Ans: The Applications covered in the Post-Traumatic Stress Disorder (PTSD) Market report are Children, Adult

What are the Type segmentation covered in the Post-Traumatic Stress Disorder (PTSD) Market report?

Ans: The Types covered in the Post-Traumatic Stress Disorder (PTSD) Market report are Cognitive Therapy, Exposure Therapy, Eye Movement Desensitization And Reprocessing (EMDR), Antidepressants, Anti-Anxiety Medications, Prazosin

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cognitive Therapy
1.2.3 Exposure Therapy
1.2.4 Eye Movement Desensitization And Reprocessing (EMDR)
1.2.5 Antidepressants
1.2.6 Anti-Anxiety Medications
1.2.7 Prazosin
1.3 Market by Application
1.3.1 Global Post-Traumatic Stress Disorder (PTSD) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Children
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Post-Traumatic Stress Disorder (PTSD) Market Perspective (2020-2031)
2.2 Global Post-Traumatic Stress Disorder (PTSD) Growth Trends by Region
2.2.1 Global Post-Traumatic Stress Disorder (PTSD) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Post-Traumatic Stress Disorder (PTSD) Historic Market Size by Region (2020-2025)
2.2.3 Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Region (2026-2031)
2.3 Post-Traumatic Stress Disorder (PTSD) Market Dynamics
2.3.1 Post-Traumatic Stress Disorder (PTSD) Industry Trends
2.3.2 Post-Traumatic Stress Disorder (PTSD) Market Drivers
2.3.3 Post-Traumatic Stress Disorder (PTSD) Market Challenges
2.3.4 Post-Traumatic Stress Disorder (PTSD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Post-Traumatic Stress Disorder (PTSD) Players by Revenue
3.1.1 Global Top Post-Traumatic Stress Disorder (PTSD) Players by Revenue (2020-2025)
3.1.2 Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Players (2020-2025)
3.2 Global Post-Traumatic Stress Disorder (PTSD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Post-Traumatic Stress Disorder (PTSD) Revenue
3.4 Global Post-Traumatic Stress Disorder (PTSD) Market Concentration Ratio
3.4.1 Global Post-Traumatic Stress Disorder (PTSD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Post-Traumatic Stress Disorder (PTSD) Revenue in 2024
3.5 Global Key Players of Post-Traumatic Stress Disorder (PTSD) Head office and Area Served
3.6 Global Key Players of Post-Traumatic Stress Disorder (PTSD), Product and Application
3.7 Global Key Players of Post-Traumatic Stress Disorder (PTSD), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Post-Traumatic Stress Disorder (PTSD) Breakdown Data by Type
4.1 Global Post-Traumatic Stress Disorder (PTSD) Historic Market Size by Type (2020-2025)
4.2 Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Type (2026-2031)
5 Post-Traumatic Stress Disorder (PTSD) Breakdown Data by Application
5.1 Global Post-Traumatic Stress Disorder (PTSD) Historic Market Size by Application (2020-2025)
5.2 Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Post-Traumatic Stress Disorder (PTSD) Market Size (2020-2031)
6.2 North America Post-Traumatic Stress Disorder (PTSD) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2020-2025)
6.4 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Post-Traumatic Stress Disorder (PTSD) Market Size (2020-2031)
7.2 Europe Post-Traumatic Stress Disorder (PTSD) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2020-2025)
7.4 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size (2020-2031)
8.2 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2020-2025)
8.4 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size (2020-2031)
9.2 Latin America Post-Traumatic Stress Disorder (PTSD) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2020-2025)
9.4 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size (2020-2031)
10.2 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2020-2025)
10.4 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline (UK)
11.1.1 GlaxoSmithKline (UK) Company Details
11.1.2 GlaxoSmithKline (UK) Business Overview
11.1.3 GlaxoSmithKline (UK) Post-Traumatic Stress Disorder (PTSD) Introduction
11.1.4 GlaxoSmithKline (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
11.1.5 GlaxoSmithKline (UK) Recent Development
11.2 Pfizer (US)
11.2.1 Pfizer (US) Company Details
11.2.2 Pfizer (US) Business Overview
11.2.3 Pfizer (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.2.4 Pfizer (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
11.2.5 Pfizer (US) Recent Development
11.3 Eli Lilly and Company (US)
11.3.1 Eli Lilly and Company (US) Company Details
11.3.2 Eli Lilly and Company (US) Business Overview
11.3.3 Eli Lilly and Company (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.3.4 Eli Lilly and Company (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
11.3.5 Eli Lilly and Company (US) Recent Development
11.4 Lundbeck A/S (Denmark)
11.4.1 Lundbeck A/S (Denmark) Company Details
11.4.2 Lundbeck A/S (Denmark) Business Overview
11.4.3 Lundbeck A/S (Denmark) Post-Traumatic Stress Disorder (PTSD) Introduction
11.4.4 Lundbeck A/S (Denmark) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
11.4.5 Lundbeck A/S (Denmark) Recent Development
11.5 Azevan Pharmaceuticals (US)
11.5.1 Azevan Pharmaceuticals (US) Company Details
11.5.2 Azevan Pharmaceuticals (US) Business Overview
11.5.3 Azevan Pharmaceuticals (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.5.4 Azevan Pharmaceuticals (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
11.5.5 Azevan Pharmaceuticals (US) Recent Development
11.6 Marinus Pharmaceuticals, Inc. (US)
11.6.1 Marinus Pharmaceuticals, Inc. (US) Company Details
11.6.2 Marinus Pharmaceuticals, Inc. (US) Business Overview
11.6.3 Marinus Pharmaceuticals, Inc. (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.6.4 Marinus Pharmaceuticals, Inc. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
11.6.5 Marinus Pharmaceuticals, Inc. (US) Recent Development
11.7 Tonix Pharmaceuticals Holding Corp. (US)
11.7.1 Tonix Pharmaceuticals Holding Corp. (US) Company Details
11.7.2 Tonix Pharmaceuticals Holding Corp. (US) Business Overview
11.7.3 Tonix Pharmaceuticals Holding Corp. (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.7.4 Tonix Pharmaceuticals Holding Corp. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
11.7.5 Tonix Pharmaceuticals Holding Corp. (US) Recent Development
11.8 Bionomics (Australia)
11.8.1 Bionomics (Australia) Company Details
11.8.2 Bionomics (Australia) Business Overview
11.8.3 Bionomics (Australia) Post-Traumatic Stress Disorder (PTSD) Introduction
11.8.4 Bionomics (Australia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
11.8.5 Bionomics (Australia) Recent Development
11.9 Greenstone LLC (US)
11.9.1 Greenstone LLC (US) Company Details
11.9.2 Greenstone LLC (US) Business Overview
11.9.3 Greenstone LLC (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.9.4 Greenstone LLC (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
11.9.5 Greenstone LLC (US) Recent Development
11.10 Mylan NV (US)
11.10.1 Mylan NV (US) Company Details
11.10.2 Mylan NV (US) Business Overview
11.10.3 Mylan NV (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.10.4 Mylan NV (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
11.10.5 Mylan NV (US) Recent Development
11.11 Otsuka Pharmaceutical (Japan)
11.11.1 Otsuka Pharmaceutical (Japan) Company Details
11.11.2 Otsuka Pharmaceutical (Japan) Business Overview
11.11.3 Otsuka Pharmaceutical (Japan) Post-Traumatic Stress Disorder (PTSD) Introduction
11.11.4 Otsuka Pharmaceutical (Japan) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
11.11.5 Otsuka Pharmaceutical (Japan) Recent Development
11.12 Prometheon Pharma (USA)
11.12.1 Prometheon Pharma (USA) Company Details
11.12.2 Prometheon Pharma (USA) Business Overview
11.12.3 Prometheon Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Introduction
11.12.4 Prometheon Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
11.12.5 Prometheon Pharma (USA) Recent Development
11.13 Ligand Pharma (USA)
11.13.1 Ligand Pharma (USA) Company Details
11.13.2 Ligand Pharma (USA) Business Overview
11.13.3 Ligand Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Introduction
11.13.4 Ligand Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
11.13.5 Ligand Pharma (USA) Recent Development
11.14 Valenta Pharm (Russia)
11.14.1 Valenta Pharm (Russia) Company Details
11.14.2 Valenta Pharm (Russia) Business Overview
11.14.3 Valenta Pharm (Russia) Post-Traumatic Stress Disorder (PTSD) Introduction
11.14.4 Valenta Pharm (Russia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
11.14.5 Valenta Pharm (Russia) Recent Development
11.15 Lycera Corp (US)
11.15.1 Lycera Corp (US) Company Details
11.15.2 Lycera Corp (US) Business Overview
11.15.3 Lycera Corp (US) Post-Traumatic Stress Disorder (PTSD) Introduction
11.15.4 Lycera Corp (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
11.15.5 Lycera Corp (US) Recent Development
11.16 Archimedes (UK)
11.16.1 Archimedes (UK) Company Details
11.16.2 Archimedes (UK) Business Overview
11.16.3 Archimedes (UK) Post-Traumatic Stress Disorder (PTSD) Introduction
11.16.4 Archimedes (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
11.16.5 Archimedes (UK) Recent Development
11.17 GMP Endotherapeutics (USA)
11.17.1 GMP Endotherapeutics (USA) Company Details
11.17.2 GMP Endotherapeutics (USA) Business Overview
11.17.3 GMP Endotherapeutics (USA) Post-Traumatic Stress Disorder (PTSD) Introduction
11.17.4 GMP Endotherapeutics (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
11.17.5 GMP Endotherapeutics (USA) Recent Development
11.18 Nuvo Pharmaceuticals (Canada)
11.18.1 Nuvo Pharmaceuticals (Canada) Company Details
11.18.2 Nuvo Pharmaceuticals (Canada) Business Overview
11.18.3 Nuvo Pharmaceuticals (Canada) Post-Traumatic Stress Disorder (PTSD) Introduction
11.18.4 Nuvo Pharmaceuticals (Canada) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
11.18.5 Nuvo Pharmaceuticals (Canada) Recent Development
11.19 Beijing Wansheng Pharmaceutical
11.19.1 Beijing Wansheng Pharmaceutical Company Details
11.19.2 Beijing Wansheng Pharmaceutical Business Overview
11.19.3 Beijing Wansheng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Introduction
11.19.4 Beijing Wansheng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
11.19.5 Beijing Wansheng Pharmaceutical Recent Development
11.20 Zhejiang Huahai Pharmaceutical
11.20.1 Zhejiang Huahai Pharmaceutical Company Details
11.20.2 Zhejiang Huahai Pharmaceutical Business Overview
11.20.3 Zhejiang Huahai Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Introduction
11.20.4 Zhejiang Huahai Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
11.20.5 Zhejiang Huahai Pharmaceutical Recent Development
11.21 Zhejiang Jianfeng Pharmaceutical
11.21.1 Zhejiang Jianfeng Pharmaceutical Company Details
11.21.2 Zhejiang Jianfeng Pharmaceutical Business Overview
11.21.3 Zhejiang Jianfeng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Introduction
11.21.4 Zhejiang Jianfeng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
11.21.5 Zhejiang Jianfeng Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
GlaxoSmithKline UK
Pfizer (US)
Eli Lilly and Company (US)
Lundbeck A/S (Denmark)
Azevan Pharmaceuticals (US)
Marinus Pharmaceuticals, Inc. (US)
Tonix Pharmaceuticals Holding Corp. (US)
Bionomics (Australia)
Greenstone LLC (US)
Mylan NV (US)
Otsuka Pharmaceutical (Japan)
Prometheon Pharma (USA)
Ligand Pharma (USA)
Valenta Pharm (Russia)
Lycera Corp (US)
Archimedes (UK)
GMP Endotherapeutics (USA)
Nuvo Pharmaceuticals (Canada)
Beijing Wansheng Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Jianfeng Pharmaceutical
List of Tables
 Table 1. Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Cognitive Therapy
 Table 3. Key Players of Exposure Therapy
 Table 4. Key Players of Eye Movement Desensitization And Reprocessing (EMDR)
 Table 5. Key Players of Antidepressants
 Table 6. Key Players of Anti-Anxiety Medications
 Table 7. Key Players of Prazosin
 Table 8. Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2020-2025) & (US$ Million)
 Table 11. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Region (2020-2025)
 Table 12. Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 13. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Region (2026-2031)
 Table 14. Post-Traumatic Stress Disorder (PTSD) Market Trends
 Table 15. Post-Traumatic Stress Disorder (PTSD) Market Drivers
 Table 16. Post-Traumatic Stress Disorder (PTSD) Market Challenges
 Table 17. Post-Traumatic Stress Disorder (PTSD) Market Restraints
 Table 18. Global Post-Traumatic Stress Disorder (PTSD) Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Players (2020-2025)
 Table 20. Global Top Post-Traumatic Stress Disorder (PTSD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-Traumatic Stress Disorder (PTSD) as of 2024)
 Table 21. Ranking of Global Top Post-Traumatic Stress Disorder (PTSD) Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Post-Traumatic Stress Disorder (PTSD) Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Post-Traumatic Stress Disorder (PTSD), Headquarters and Area Served
 Table 24. Global Key Players of Post-Traumatic Stress Disorder (PTSD), Product and Application
 Table 25. Global Key Players of Post-Traumatic Stress Disorder (PTSD), Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2020-2025) & (US$ Million)
 Table 28. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Type (2020-2025)
 Table 29. Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 30. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Type (2026-2031)
 Table 31. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2020-2025) & (US$ Million)
 Table 32. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Application (2020-2025)
 Table 33. Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 34. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Application (2026-2031)
 Table 35. North America Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2020-2025) & (US$ Million)
 Table 37. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Europe Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2020-2025) & (US$ Million)
 Table 40. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2020-2025) & (US$ Million)
 Table 43. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2026-2031) & (US$ Million)
 Table 44. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2026-2031) & (US$ Million)
 Table 50. GlaxoSmithKline (UK) Company Details
 Table 51. GlaxoSmithKline (UK) Business Overview
 Table 52. GlaxoSmithKline (UK) Post-Traumatic Stress Disorder (PTSD) Product
 Table 53. GlaxoSmithKline (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025) & (US$ Million)
 Table 54. GlaxoSmithKline (UK) Recent Development
 Table 55. Pfizer (US) Company Details
 Table 56. Pfizer (US) Business Overview
 Table 57. Pfizer (US) Post-Traumatic Stress Disorder (PTSD) Product
 Table 58. Pfizer (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025) & (US$ Million)
 Table 59. Pfizer (US) Recent Development
 Table 60. Eli Lilly and Company (US) Company Details
 Table 61. Eli Lilly and Company (US) Business Overview
 Table 62. Eli Lilly and Company (US) Post-Traumatic Stress Disorder (PTSD) Product
 Table 63. Eli Lilly and Company (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025) & (US$ Million)
 Table 64. Eli Lilly and Company (US) Recent Development
 Table 65. Lundbeck A/S (Denmark) Company Details
 Table 66. Lundbeck A/S (Denmark) Business Overview
 Table 67. Lundbeck A/S (Denmark) Post-Traumatic Stress Disorder (PTSD) Product
 Table 68. Lundbeck A/S (Denmark) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025) & (US$ Million)
 Table 69. Lundbeck A/S (Denmark) Recent Development
 Table 70. Azevan Pharmaceuticals (US) Company Details
 Table 71. Azevan Pharmaceuticals (US) Business Overview
 Table 72. Azevan Pharmaceuticals (US) Post-Traumatic Stress Disorder (PTSD) Product
 Table 73. Azevan Pharmaceuticals (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025) & (US$ Million)
 Table 74. Azevan Pharmaceuticals (US) Recent Development
 Table 75. Marinus Pharmaceuticals, Inc. (US) Company Details
 Table 76. Marinus Pharmaceuticals, Inc. (US) Business Overview
 Table 77. Marinus Pharmaceuticals, Inc. (US) Post-Traumatic Stress Disorder (PTSD) Product
 Table 78. Marinus Pharmaceuticals, Inc. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025) & (US$ Million)
 Table 79. Marinus Pharmaceuticals, Inc. (US) Recent Development
 Table 80. Tonix Pharmaceuticals Holding Corp. (US) Company Details
 Table 81. Tonix Pharmaceuticals Holding Corp. (US) Business Overview
 Table 82. Tonix Pharmaceuticals Holding Corp. (US) Post-Traumatic Stress Disorder (PTSD) Product
 Table 83. Tonix Pharmaceuticals Holding Corp. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025) & (US$ Million)
 Table 84. Tonix Pharmaceuticals Holding Corp. (US) Recent Development
 Table 85. Bionomics (Australia) Company Details
 Table 86. Bionomics (Australia) Business Overview
 Table 87. Bionomics (Australia) Post-Traumatic Stress Disorder (PTSD) Product
 Table 88. Bionomics (Australia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025) & (US$ Million)
 Table 89. Bionomics (Australia) Recent Development
 Table 90. Greenstone LLC (US) Company Details
 Table 91. Greenstone LLC (US) Business Overview
 Table 92. Greenstone LLC (US) Post-Traumatic Stress Disorder (PTSD) Product
 Table 93. Greenstone LLC (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025) & (US$ Million)
 Table 94. Greenstone LLC (US) Recent Development
 Table 95. Mylan NV (US) Company Details
 Table 96. Mylan NV (US) Business Overview
 Table 97. Mylan NV (US) Post-Traumatic Stress Disorder (PTSD) Product
 Table 98. Mylan NV (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025) & (US$ Million)
 Table 99. Mylan NV (US) Recent Development
 Table 100. Otsuka Pharmaceutical (Japan) Company Details
 Table 101. Otsuka Pharmaceutical (Japan) Business Overview
 Table 102. Otsuka Pharmaceutical (Japan) Post-Traumatic Stress Disorder (PTSD) Product
 Table 103. Otsuka Pharmaceutical (Japan) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025) & (US$ Million)
 Table 104. Otsuka Pharmaceutical (Japan) Recent Development
 Table 105. Prometheon Pharma (USA) Company Details
 Table 106. Prometheon Pharma (USA) Business Overview
 Table 107. Prometheon Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Product
 Table 108. Prometheon Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025) & (US$ Million)
 Table 109. Prometheon Pharma (USA) Recent Development
 Table 110. Ligand Pharma (USA) Company Details
 Table 111. Ligand Pharma (USA) Business Overview
 Table 112. Ligand Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Product
 Table 113. Ligand Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025) & (US$ Million)
 Table 114. Ligand Pharma (USA) Recent Development
 Table 115. Valenta Pharm (Russia) Company Details
 Table 116. Valenta Pharm (Russia) Business Overview
 Table 117. Valenta Pharm (Russia) Post-Traumatic Stress Disorder (PTSD) Product
 Table 118. Valenta Pharm (Russia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025) & (US$ Million)
 Table 119. Valenta Pharm (Russia) Recent Development
 Table 120. Lycera Corp (US) Company Details
 Table 121. Lycera Corp (US) Business Overview
 Table 122. Lycera Corp (US) Post-Traumatic Stress Disorder (PTSD) Product
 Table 123. Lycera Corp (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025) & (US$ Million)
 Table 124. Lycera Corp (US) Recent Development
 Table 125. Archimedes (UK) Company Details
 Table 126. Archimedes (UK) Business Overview
 Table 127. Archimedes (UK) Post-Traumatic Stress Disorder (PTSD) Product
 Table 128. Archimedes (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025) & (US$ Million)
 Table 129. Archimedes (UK) Recent Development
 Table 130. GMP Endotherapeutics (USA) Company Details
 Table 131. GMP Endotherapeutics (USA) Business Overview
 Table 132. GMP Endotherapeutics (USA) Post-Traumatic Stress Disorder (PTSD) Product
 Table 133. GMP Endotherapeutics (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025) & (US$ Million)
 Table 134. GMP Endotherapeutics (USA) Recent Development
 Table 135. Nuvo Pharmaceuticals (Canada) Company Details
 Table 136. Nuvo Pharmaceuticals (Canada) Business Overview
 Table 137. Nuvo Pharmaceuticals (Canada) Post-Traumatic Stress Disorder (PTSD) Product
 Table 138. Nuvo Pharmaceuticals (Canada) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025) & (US$ Million)
 Table 139. Nuvo Pharmaceuticals (Canada) Recent Development
 Table 140. Beijing Wansheng Pharmaceutical Company Details
 Table 141. Beijing Wansheng Pharmaceutical Business Overview
 Table 142. Beijing Wansheng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product
 Table 143. Beijing Wansheng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025) & (US$ Million)
 Table 144. Beijing Wansheng Pharmaceutical Recent Development
 Table 145. Zhejiang Huahai Pharmaceutical Company Details
 Table 146. Zhejiang Huahai Pharmaceutical Business Overview
 Table 147. Zhejiang Huahai Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product
 Table 148. Zhejiang Huahai Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025) & (US$ Million)
 Table 149. Zhejiang Huahai Pharmaceutical Recent Development
 Table 150. Zhejiang Jianfeng Pharmaceutical Company Details
 Table 151. Zhejiang Jianfeng Pharmaceutical Business Overview
 Table 152. Zhejiang Jianfeng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product
 Table 153. Zhejiang Jianfeng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025) & (US$ Million)
 Table 154. Zhejiang Jianfeng Pharmaceutical Recent Development
 Table 155. Research Programs/Design for This Report
 Table 156. Key Data Information from Secondary Sources
 Table 157. Key Data Information from Primary Sources
 Table 158. Authors List of This Report


List of Figures
 Figure 1. Post-Traumatic Stress Disorder (PTSD) Picture
 Figure 2. Global Post-Traumatic Stress Disorder (PTSD) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Type: 2024 VS 2031
 Figure 4. Cognitive Therapy Features
 Figure 5. Exposure Therapy Features
 Figure 6. Eye Movement Desensitization And Reprocessing (EMDR) Features
 Figure 7. Antidepressants Features
 Figure 8. Anti-Anxiety Medications Features
 Figure 9. Prazosin Features
 Figure 10. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2020-2031) & (US$ Million)
 Figure 11. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Application: 2024 VS 2031
 Figure 12. Children Case Studies
 Figure 13. Adult Case Studies
 Figure 14. Post-Traumatic Stress Disorder (PTSD) Report Years Considered
 Figure 15. Global Post-Traumatic Stress Disorder (PTSD) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Post-Traumatic Stress Disorder (PTSD) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Region: 2024 VS 2031
 Figure 18. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Players in 2024
 Figure 19. Global Top Post-Traumatic Stress Disorder (PTSD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-Traumatic Stress Disorder (PTSD) as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Post-Traumatic Stress Disorder (PTSD) Revenue in 2024
 Figure 21. North America Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Post-Traumatic Stress Disorder (PTSD) Market Share by Country (2020-2031)
 Figure 23. United States Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Post-Traumatic Stress Disorder (PTSD) Market Share by Country (2020-2031)
 Figure 27. Germany Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Share by Region (2020-2031)
 Figure 35. China Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Post-Traumatic Stress Disorder (PTSD) Market Share by Country (2020-2031)
 Figure 43. Mexico Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Share by Country (2020-2031)
 Figure 47. Turkey Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. GlaxoSmithKline (UK) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
 Figure 51. Pfizer (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
 Figure 52. Eli Lilly and Company (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
 Figure 53. Lundbeck A/S (Denmark) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
 Figure 54. Azevan Pharmaceuticals (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
 Figure 55. Marinus Pharmaceuticals, Inc. (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
 Figure 56. Tonix Pharmaceuticals Holding Corp. (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
 Figure 57. Bionomics (Australia) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
 Figure 58. Greenstone LLC (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
 Figure 59. Mylan NV (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
 Figure 60. Otsuka Pharmaceutical (Japan) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
 Figure 61. Prometheon Pharma (USA) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
 Figure 62. Ligand Pharma (USA) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
 Figure 63. Valenta Pharm (Russia) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
 Figure 64. Lycera Corp (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
 Figure 65. Archimedes (UK) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
 Figure 66. GMP Endotherapeutics (USA) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
 Figure 67. Nuvo Pharmaceuticals (Canada) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
 Figure 68. Beijing Wansheng Pharmaceutical Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
 Figure 69. Zhejiang Huahai Pharmaceutical Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
 Figure 70. Zhejiang Jianfeng Pharmaceutical Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2020-2025)
 Figure 71. Bottom-up and Top-down Approaches for This Report
 Figure 72. Data Triangulation
 Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Post Traumatic Stress Disorder PTSD Therapeutics Market Research Report 2024
Global Post Traumatic Stress Disorder Therapeutics Market Insights Forecast to 2030
Post traumatic Stress Disorder Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anxiety Disorders Treatment Market Insights Forecast to 2030
Global Traumatic Brain Injury Therapeutics Market Research Report 2025
Global Spinal Cord Trauma Treatment Market Insights Forecast to 2030
Global Chronic Traumatic Encephalopathy CTE Market Insights Forecast to 2030
Global Online Trauma Therapy Service Market Research Report 2024
Global Obsessive Compulsive Disorder Medicine Market Research Report 2025
Global Obsessive Compulsive Disorder Drugs Market Insights Forecast to 2030
Traumatic Brain Injury TBI Testing Biomarkers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bipolar Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Opioid Use Disorder Market Insights Forecast to 2030
Global Precision Psychiatry Market Research Report 2024
Global Trauma Informed Therapy Service Market Research Report 2024
Agoraphobia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Acquired Hemophilia Treatment Market Insights Forecast to 2030
Global Mental Health Technology Market Insights Forecast to 2030
Global Trauma Devices Market Insights Forecast to 2030
Global Trauma Training Models Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions